Cargando…
Neuroinflammation in Parkinson’s Disease – Putative Pathomechanisms and Targets for Disease-Modification
Parkinson’s disease (PD) is a progressive and debilitating chronic disease that affects more than six million people worldwide, with rising prevalence. The hallmarks of PD are motor deficits, the spreading of pathological α-synuclein clusters in the central nervous system, and neuroinflammatory proc...
Autores principales: | Grotemeyer, Alexander, McFleder, Rhonda Leah, Wu, Jingjing, Wischhusen, Jörg, Ip, Chi Wang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158130/ https://www.ncbi.nlm.nih.gov/pubmed/35663989 http://dx.doi.org/10.3389/fimmu.2022.878771 |
Ejemplares similares
-
Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-α-synuclein Parkinson’s disease mice
por: Badr, Mohammad, et al.
Publicado: (2022) -
Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson’s Disease Targeting Neuroinflammation
por: Chen, Chiung-Mei, et al.
Publicado: (2021) -
Versatile guardians: regenerative regulatory T cells in Parkinson’s disease rodent models
por: Ip, Chi Wang, et al.
Publicado: (2023) -
Brain-to-gut trafficking of alpha-synuclein by CD11c(+) cells in a mouse model of Parkinson’s disease
por: McFleder, Rhonda L., et al.
Publicado: (2023) -
Pathomechanisms of Autoimmune Based Testicular Inflammation
por: Lustig, Livia, et al.
Publicado: (2020)